Literature DB >> 6369481

Interleukin-1.

C A Dinarello.   

Abstract

For the past 30 years, considerable experimentation on the mechanisms of host responses to infection has centered on soluble products derived from phagocytic cells. The biologic activities of some of these products include fever mediated by endogenous pyrogen (EP) and induction of acute-phase responses by leukocytic endogenous mediator (LEM), EP and LEM have been characterized and purified and appear to be closely related, if not identical, molecules. Lymphocyte-activating factor (LAF), a recently described polypeptide that acts on lymphocytes, shares many of the physical properties of EP and LEM; when incubated with lymphocytes, purified EP/LEM is indistinguishable from LAF. The term interleukin-1 (IL-1) is now used to describe LAF, EP, and LEM as a single molecule or as a family of closely related molecules, although at present there is no known sequence analysis of EP, LEM, or LAF. In this review, experimental and clinical data are presented that link mediation of host responses to infection and inflammation to the production and activity of IL-1. Cell sources and inducers of IL-1 are discussed, as are its chemical nature and mechanisms of action. In addition, the importance of IL-1 and its effects on host defense mechanisms are presented. For example, how IL-1-mediated responses, such as elevated temperature, lymphocyte activation, and systemic metabolic changes, alter the host as well as the invading microbe are considered. The conclusions of this review are (1) that IL-1 is a key mediator of host responses to microbial invasion, (2) that IL-1 represents a true hormone produced during infection and inflammation, and (3) that its biologic activities account for several aspects of the acute-phase reaction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6369481     DOI: 10.1093/clinids/6.1.51

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  380 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

2.  Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1.

Authors:  A Morimoto; N Murakami; T Nakamori; Y Sakata; T Watanabe
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

3.  Proliferation in vitro of Lyt2-,L3T4- thymocytes shows responsiveness to interleukin 1.

Authors:  G Chaudhri; I A Clark; R Ceredig
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

4.  Specific inhibition of OKT3-driven T-cell mitogenesis by an anti HLA-class I monoclonal antibody.

Authors:  I Beckman; X Xiaoning; J Bradley
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

5.  Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type.

Authors:  G C Bagby; C A Dinarello; R C Neerhout; D Ridgway; E McCall
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta.

Authors:  S E Goldblum; K Yoneda; D A Cohen; C J McClain
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

8.  Multiple control of fever production in the central nervous system of rabbits.

Authors:  A Morimoto; N Murakami; T Nakamori; T Watanabe
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

9.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

10.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.